This is a working overview of Tuftsin analog, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-04-29 and is reviewed periodically as new material appears.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
| Property | Value | Notes |
|---|---|---|
| Typical purity report | 95% or higher by HPLC | Area percentage at 214 nm |
| Identity confirmation | Mass spectrometry | Electrospray or MALDI |
| Powder storage | -20 C, desiccated | Protect from light |
| Solution storage | 2-8 C short term | Freeze aliquots for longer |
| Quality document | Certificate of analysis | States method and value |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
=== Gradual dissolution === In March 2002, the governments of Montenegro and Serbia, along with the Federal Republic of Yugoslavia (FRY), signed the Accord on Principles in Relations between Serbia and Montenegro (commonly known as the Belgrade Agreement), which outlined the restructuring of their mutual relations. This agreement led to the adoption of the Constitutional Charter of Serbia and Montenegro on 4 February 2003, officially transforming the FRY into the State Union of Serbia and Montenegro and formally retiring the name "Yugoslavia" after 74 years. The Constitutional Charter included a provision allowing either republic to hold a referendum on independence after a three-year transition period. On 21 May 2006, Montenegro held such a referendum. The final results showed that 55.5% of voters supported independence, narrowly surpassing the 55% threshold set by the European Union for the referendum's validity. Voter turnout was 86.5%. Following the referendum, Montenegro's parliament formally declared independence on 3 June 2006. Subsequently, on 5 June 2006, Serbia's parliament did the same, effectively dissolving the union and marking the final chapter in the disintegration of the former Yugoslavia.
=== Acute kidney injury === Ferroptosis occurs during acute kidney injury in various cellular and animal models. Deficiencies in ferroptosis suppressor enzymes such as GPX4 and FSP1 sensitize kidneys to tubular ferroptosis during kidney IRI, thus inhibition of ferroptosis may be of therapeutic benefit. However, in premenopausal women this therapeutic potential might be limited due to intrinsic anti-ferroptotic effects of estrogen. During chemotherapy treatment, ferroptosis contributes to acute kidney injury. Reagents to image ferroptosis have been developed to monitor anticancer drug-induced acute kidney injury in mouse models.
=== Mechanism of action === Alitretinoin is believed to be the endogenous ligand (a substance that naturally occurs in the body that activates this receptor) for retinoid X receptor, but it also activates the retinoic acid receptor. More specifically, alitretinoin is believed to act on intracellular nuclear receptors of the RAR and RXR subtypes. The activated receptors function as transcription factors, which subsequently influence cell proliferation and cell differentiation. Alitretinoin acts on both keratinocytes and dendritic cells. In keratinocytes, it reduces cytokine expression, while in dendritic cells it inhibits the upregulation of the maturation marker CD83 and the co-stimulatory molecules CD80 and CD86. Consequently, these dendritic cells exhibit diminished T cell activation capacity.
=== Pulmonary and tricuspid valve disorders === Pulmonary and tricuspid valve diseases are right heart diseases. Pulmonary valve diseases are the least common heart valve disease in adults. Pulmonary valve stenosis is often the result of congenital malformations and is observed in isolation or as part of a larger pathologic process, as in Tetralogy of Fallot, Noonan syndrome, and congenital rubella syndrome. Unless the degree of stenosis is severe, individuals with pulmonary stenosis usually have excellent outcomes and better treatment options. Often patients do not require intervention until later in adulthood as a consequence of calcification that occurs with aging. Pulmonary valve insufficiency occurs commonly in healthy individuals to a very mild extent and does not require intervention. More appreciable insufficiency is typically the result of damage to the valve due to cardiac catheterization, intra-aortic balloon pump insertion, or other surgical manipulations. Additionally, insufficiency may be the result of carcinoid syndrome, inflammatory processes such a rheumatoid disease or endocarditis, or congenital malformations. It may also be secondary to severe pulmonary hypertension. Tricuspid valve stenosis without co-occurrent regurgitation is highly uncommon and typically the result of rheumatic disease. It may also be the result of congenital abnormalities, carcinoid syndrome, obstructive right atrial tumors (typically lipomas or myxomas), or hypereosinophilic syndromes. Minor tricuspid insufficiency is common in healthy individuals.
Sources: en.wikipedia.org
Newton used "indigo" to describe one of the two new primary colors he added to the five he had originally named, in his revised account of the rainbow in Lectiones Opticae of 1675. Because of its high value as a trading commodity, indigo was often referred to as blue gold. In the early days of Islam, Christians were expected to wear a blue turban or mantle to identify them. In Egypt, which was majority Christian and remained so for generations, this created a high demand for blue dye, particularly indigo. Even though regulation of the distinguishing dress relaxed from the 10-16th centuries, indigo remained a significant part of the Egyptian economy. It lost its Christian connotations and became the color of the people's dress, because it was plentiful and cheap. It remained so until the 19th century. The British taxed farmers who grew indigo to encourage people to grow cotton, and restricted water use in favor of cotton. This also affected flax, which had been a popular local fiber for indigo dyers. This, paired with the import of cheap black cotton fabrics from Britain, caused blue to fall out of favor in Egyptian women's dress in the early 20th century. Egyptian men continued to wear indigo for some time, but the total preference for the dye waned as well. Blue was also a mourning color, and mourning women would dye their faces, arms, and hands blue for the week after the death and periodic grave visitations. Blue cloths were worn and waved around at these times as well to accompany the women's wailing.
== External links == Tetrodotoxin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Tetrodotoxin: essential data (1999) Tetrodotoxin from the Bad Bug Book at the U.S. Food and Drug Administration website New York Times, "Whatever Doesn't Kill Some Animals Can Make Them Deadly" U.S. National Library of Medicine: Hazardous Substances Databank – Tetrodotoxin
=== 16 September === The RSF carried out a drone attack that destroyed an ammunition dump within the garrison of the SAF's Fifth Division in El Obeid, resulting in an unspecified number of casualties.
Sources: en.wikipedia.org
=== Medications === Certain medications can cause either weight loss or weight gain. Side effects are often listed for each medication and should be considered when attempting to manage a person's weight. Semaglutide is an anti-obesity drug that is also used for blood sugar control.
With the Regents of the University of California still holding their (earlier) view that their university's Charter precluded any commercial activity, the Regents and Robertson eventually came to the extraordinary (at the time) arrangement (UC.5) of creating an external-to-the-university entity to manage the patent and "apply any unexpended balance of such proceeds, profits or returns to research work in Medicine and preferably in the Physiology, Chemistry and Pathology of Growth either under the auspices of the University of California or otherwise ... [or] such research work be conducted in part in Australia, either under the auspices of some institution of learning there or otherwise". Robertson and five others from the University of California formed the entity's first Board of Directors: Herbert McLean Evans (Professor of Anatomy), Frederick Parker Gay (Professor of Pathology), T. Brailsford Robertson (Professor of Biochemistry and Pharmacology), Carl Louis August Schmidt (Research Assistant in Pathology), and George Hoyt Whipple (Director of the Hooper Foundation for Medical Research and Professor of Research Medicine); and, once the Board of Directors had been appointed, the university granted a five year exclusive license in September 1917 to the H. K. Mulford Company "to manufacture and sell the compound known as Tethelin at its factory in the City of Philadelphia, State of Pennsylvania". "In 1923, by the end of Mulford's five-year contract, the university's royalties on sales of tethelin amounted to only $272.47" (CW.1, p. 35).
== Activators and inhibitors == FFAR2 and FFR3 are activated primarily by short-chain fatty acids (SCFAs) that are 2 to 6 carbons in length (see length of fatty acids). In humans, acetic acid, which has 2 carbon atoms, is a strong activator of FFAR2 but very weak activator of FFAR3; propionic and butyric acids, which have 3 and 4 carbons, respectively, are strong activators of both FFAR2 and FFAR3; pentanoic acid, which has 5 carbon atoms, is a weak activator of FFAR2 but strong activator of FFAR3; and hexanoic acid, which has 6 carbon atoms, is a weak activator of FFAR3 but its effect on FFAR2 has not been reported. More recently, the ketone body fatty acid, acetoacetic acid, while not classified as a SCFA, has been shown to activate FFAR2 with a potency similar to acetic and propionic acids. Many drugs have been developed that bind to and regulate FFAR2's activity. 1) MOMBA, Sorbate, and Compound 1 are orthostatic agonists, i.e., they bind to the same site as SCFAs to activate FFAR2. 2) Compound 58 and AZ1729 are positive allosteric agonists, i.e., they bind to FFAR2 at a site different than the orthostatic binding site and do not by themselves alter FFAR2 activity but enhance the ability of SCFAs and other FFAR2 orthostatic agonists to activate FFAR2. 3) CATPB and BTI-A-404 are reverse agonists, i.e., they bind to the same site as SCFAs but induce a response opposite to that induced by SCFAs.4) 4-CMTB and TUG-1375 are classified as FFAR2 agonists but studies are needed to define their binding sites on FFAR2.
Sources: en.wikipedia.org
Purity is usually reported as an HPLC area percentage, most often measured at 214 nm. Identity is confirmed separately by mass spectrometry. A certificate of analysis should state both the method and the observed value.
Dry powder is kept frozen, desiccated, and shielded from light. Dissolved material is aliquoted and frozen to limit freeze-thaw cycles. Short-term refrigerated storage is common for working solutions.
Russia registers it as a prescription nasal product. Most other markets classify it as a research chemical with no approved medical use. Oversight of purity and labeling is consequently minimal in those markets.
Dry powder is normally held at -20 degrees Celsius or below in a sealed, light-protected container with desiccant. Brief room-temperature handling during weighing is generally tolerated. Storage instructions vary between suppliers, so the accompanying certificate of analysis should be followed.